APP下载

微导管成袢技术超选颅内锐角血管或动脉瘤的安全有效性

2016-05-14季明李瑞中

中外医疗 2016年5期
关键词:安全性

季明 李瑞中

[摘要] 目的 研究分析微导管成袢技术超选颅内锐角血管或动脉瘤的安全有效性。 方法 整群选取该院2011年6月—2015年6月期间收治的颅内动脉瘤患者187例,通过DSA明确诊断颅内伴有动静脉畸形或静脉瘘,均通过微导丝与微导管塑型成袢技术超选治疗。 结果 187例颅内动脉瘤患者通过微导管成袢技术塑型治疗,均成功完成手术操作,其责任动脉保留较为良好。术后即可造影结果中169例患者为稳定,13例为再通,5例为血栓形成。术后7例患者出现轻度血管痉挛,其中2例发生血管事件。拉斯哥预后评分结果中171例患者术后恢复良好,达到5分,余下16例患者术后症状明显缓解,拉斯哥预后评分为3~4分。 结论 在治疗锐角血管或动脉瘤中采用微导管成袢技术超选介入,手术成功率较高,并且疗效确切,安全性得到了明显提升,值得临床广泛应用。

[关键词] 微导管;成袢技术;颅内动脉瘤;血管治疗;安全性

[中图分类号] R4 [文献标识码] A [文章编号] 1674-0742(2016)02(b)-0106-02

[Abstract] Objective To research and analyze the safety and effectiveness of microtubule looping technique super-selective treatment for intracranial acute vascular or arterial aneurysm. Methods 187 cases of patients with intracranial arterial aneurysm treated in our hospital from June 2011 to June 2015 were selected and definitely diagnosed with intracranial arteriovenous malformation or venous fistula through DSA, and they were given super-selective treatment by microguide wire and microtubule molding looping technique. Results All patients had successfully finished operation and the offending artery retention of the patients was good, the immediate angiographic results after operation showed that 169 cases were steady, 13 cases were repatency, 5 cases were thrombopoiesis, 7 cases were with mild vascular spasm after operation, among them, 2 cases were with vascular events, the Glasgow prognosis score showed that 171 cases had a good recovery after operation and the score reached 5, the symptoms after operation of the other 16 cases were obviously relieved and the score reached 3~4. Conclusion Microtubule looping technique super-selective intervention in treatment of acute vascular or arterial aneurysm has a higher operation successful rate and the curative effect is definite, the security is obviously improved, which is worth wide application in clinic.

[Key words] Microtubule; Looping technique; Intracranial arterial aneurysm; Vascular treatment; Security

颅内动脉瘤多是由于颅内动脉壁出现局部扩张形成血管肿瘤样包块,有相关研究报道,颅内动脉瘤属目前全球脑血管疾病位居第三,同时也是诱发造成蛛网膜下腔出血SAH的主要病因,该病症可导致患者残疾甚至死亡,严重影响了患者生存质量[1-2]。近几年随着导管技术及栓塞材料的部分推进更新,血管内介入性治疗方式也逐渐广泛应用于临床,其微创、疗效等特点也得到了广大患者认可。不过对于部分颅内动脉瘤因病变血管位置较为特殊,采用常规的介入性导管预塑形技术不足以完成,而通过微导管成袢技术,对小角度血管行超选治疗则能够很好的解决上述问题[3]。……

登录APP查看全文

猜你喜欢

安全性
两款输液泵的输血安全性评估
新染料可提高电动汽车安全性
既有建筑工程质量安全性的思考
某既有隔震建筑检测与安全性鉴定
基于安全性需求的高升力控制系统架构设计
加强广播电视信息安全性的思考
网约车安全性提高研究
注意药酒服用的安全性
田间施用灭幼脲在桃中的残留安全性评估
ApplePay横空出世 安全性遭受质疑 拿什么保护你,我的苹果支付?